Sandbox 09232014: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 46: | Line 46: | ||
! style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Implicated medications}} | ! style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Implicated medications}} | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Pulmonary | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Pulmonary fibrosis, hypersensitivity pneumonitis | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[ | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Nitrofurantoin]], [[bleomycin]], [[methotrexate]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Hepatic | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Hepatic | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Hepatitis, | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Hepatitis, cholestasis | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Aminosalicylic acid|Para-aminosalicylic acid]], [[sulfonamides]], [[phenothiazines]] | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Aminosalicylic acid|Para-aminosalicylic acid]], [[sulfonamides]], [[phenothiazines]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Renal | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Renal | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Interstitial nephritis, membranous glomerulonephritis | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Interstitial nephritis, membranous glomerulonephritis | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Penicillin]], [[sulfonamides]], [[gold]], [[penicillamine]], [[allopurinol]] | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Penicillin]], [[sulfonamides]], [[gold]], [[penicillamine]], [[allopurinol]] | ||
|- | |||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Hematologic | |||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Hemolytic anemia, thrombocytopenia, granulocytopenia | |||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Penicillin]], [[quinine]], [[sulfonamides]] | |||
|} | |} | ||
Line 70: | Line 70: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Anaphylaxis | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Anaphylaxis | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Urticaria, angioedema, bronchospasm, gastrointestinal symptoms, hypotension | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Urticaria, angioedema, bronchospasm, gastrointestinal symptoms, hypotension | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Beta-lactam|β-lactam antibiotics]], [[monoclonal antibodies]] | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Beta-lactam|β-lactam antibiotics]], [[monoclonal antibodies]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Systemic lupus erythematosus | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Systemic lupus erythematosus | ||
Line 88: | Line 80: | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Cutaneous or visceral vasculitis | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Cutaneous or visceral vasculitis | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Hydralazine]], [[penicillamine]], [[propylthiouracil]] | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Hydralazine]], [[penicillamine]], [[propylthiouracil]] | ||
|- | |||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Serum sickness | |||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Urticaria, arthralgia, fever | |||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Heterologous]] [[antibodies]], [[infliximab]] | |||
|- | |||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Drug reaction with eosinophilia and systemic symptoms (DRESS) | |||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Cutaneous eruption, fever, eosinophilia, hepatic dysfunction, lymphadenopathy | |||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Anticonvulsant]]s, [[sulfonamide]]s, [[minocycline]], [[allopurinol]] | |||
|} | |} | ||
Revision as of 19:16, 23 September 2014
Cutaneous reactions | Clnical features | Implicated medications |
---|---|---|
Exanthems | Delayed-type hypersensitivity Evolve over days after drug initiation Diffuse macules and papules |
Aminopenicillins, antibacterial sulfonamides, cephalosporins, allopurinol, anticonvulsants |
Urticaria/ angioedema | Often IgE mediated Onset within minutes of drug initiation |
β-lactam antibiotics, ACEIs |
Fixed drug eruption | Hyperpigmented plaques that recur at same skin or mucosal site | NSAIDs, tetracycline, carbamazepine |
Pustules | Acute generalized eczematous pustulosis (AGEP) Acneiform |
AGEP: antibiotics, calcium-channel blockers Acneiform: corticosteroids, sirolimus |
Bullous | Flaccid blisters Tense blisters |
Flaccid blisters: captopril, penicillamine Tense blisters: furosemide, vancomycin |
Cutaneous lupus erythematosus | Erythematous/scaly plaques in photodistribution | Hydrochlorothiazide, calcium-channel blockers, ACEIs |
Stevens-Johnson syndrome (SJS) | Purpuric macules on face and trunk with <10% epidermal detachment, fever, stomatitis, ocular involvement | Antibacterial sulfonamides, oxicam NSAIDs, anticonvulsants, allopurinol |
Toxic epidermal necrolysis (TEN) | Similar to SJS but >30% epidermal detachment | Antibacterial sulfonamides, oxicam NSAIDs, anticonvulsants, allopurinol |
Organ-specific reactions | Clnical features | Implicated medications |
---|---|---|
Pulmonary | Pulmonary fibrosis, hypersensitivity pneumonitis | Nitrofurantoin, bleomycin, methotrexate |
Hepatic | Hepatitis, cholestasis | Para-aminosalicylic acid, sulfonamides, phenothiazines |
Renal | Interstitial nephritis, membranous glomerulonephritis | Penicillin, sulfonamides, gold, penicillamine, allopurinol |
Hematologic | Hemolytic anemia, thrombocytopenia, granulocytopenia | Penicillin, quinine, sulfonamides |
Multiorgan reactions | Clnical features | Implicated medications |
---|---|---|
Anaphylaxis | Urticaria, angioedema, bronchospasm, gastrointestinal symptoms, hypotension | β-lactam antibiotics, monoclonal antibodies |
Systemic lupus erythematosus | Arthralgia, myalgias, fever, malaise | Hydralazine, procainamide, isoniazid |
Vasculitis | Cutaneous or visceral vasculitis | Hydralazine, penicillamine, propylthiouracil |
Serum sickness | Urticaria, arthralgia, fever | Heterologous antibodies, infliximab |
Drug reaction with eosinophilia and systemic symptoms (DRESS) | Cutaneous eruption, fever, eosinophilia, hepatic dysfunction, lymphadenopathy | Anticonvulsants, sulfonamides, minocycline, allopurinol |